SYSTEMATIC REVIEW
Accepted on 17 Sep 2025
Association between the expression status of programmed cell death ligand 1 and the efficacy of pan-cancer neoadjuvant immune checkpoint blockade
doi 10.3389/fimmu.2025.1617905
- 166 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume III
Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume III
3,306
Total downloads
15k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 13 Aug 2025
Multidimensional insights into exosomes in hepatocellular carcinoma: from genesis to clinical application
doi 10.3389/fimmu.2025.1628573
- 1,161 views
ORIGINAL RESEARCH
Published on 08 Aug 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinoma
doi 10.3389/fonc.2025.1622008
- 1,203 views
SYSTEMATIC REVIEW
Published on 26 Jun 2025
The prognostic and clinicopathological value of HALP score in non-small cell lung cancer
doi 10.3389/fimmu.2025.1576326
- 2,462 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC
doi 10.3389/fimmu.2025.1578422
- 1,793 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis
doi 10.3389/fonc.2025.1547067
- 1,007 views
ORIGINAL RESEARCH
Published on 22 May 2025
Expression of PSMD14 in lung adenocarcinoma and its impact on immune cell infiltration and prognosis: a comprehensive analysis based on RNA and single-cell RNA sequencing
doi 10.3389/fimmu.2025.1560693
- 1,788 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
doi 10.3389/fimmu.2025.1559317
- 1,995 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: